What do food and beverage manufacturers need to know
Similar content being viewed by others Introduction/background Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) are a class of medications increasingly utilized in the treatment of type 2 diabetes and, more recently, obesity (Nathan et al
1 2 3 4 5 6 Pharmacology & Therapeutics
If, after consulting with a doctor, a young athlete is going to begin using a GLP-1 drug, its important to monitor the mental health and body image of your athlete, as well as their physical health
This time point captures the metabolic steady state after drug washout and compensatory hormonal recalibration
To explore this further, researchers observed 40 adults with obesity over a three-month period